Shares of hVIVO plc (LON:HVO – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 28.04 ($0.35) and traded as high as GBX 28.50 ($0.35). hVIVO shares last traded at GBX 27.20 ($0.34), with a volume of 1,771,474 shares.
hVIVO Trading Down 2.1 %
The company has a quick ratio of 1.16, a current ratio of 1.46 and a debt-to-equity ratio of 9.83. The business’s fifty day moving average is GBX 27.94 and its 200-day moving average is GBX 24.25. The stock has a market capitalization of £183.77 million, a PE ratio of -1.00 and a beta of 0.99.
hVIVO Cuts Dividend
The company also recently announced a dividend, which will be paid on Monday, May 20th. Investors of record on Thursday, April 18th will be given a GBX 0.20 ($0.00) dividend. This represents a dividend yield of 0.68%. The ex-dividend date is Thursday, April 18th.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Comprehensive PepsiCo Stock Analysis
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Calculate Options Profits
- Bear Market Funds to Watch This Year
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.